Searchable abstracts of presentations at key conferences in endocrinology

ea0073aep109 | Calcium and Bone | ECE2021

Frequency of metabolic syndrome in Paget’s disease of bone

Erol Selvinaz , Sen Esra Cil , Ozturk Feyza Yener , M. Masum Canat , Alayci Birkan , Altuntas Yuksel

ObjectiveScanty data about glucose metabolism, hypertension and metabolic syndrome (MS) have been reported in Paget’s disease of bone (PDB) to be related with increased cardiovascular mortality. We aimed to determine prevalence of metabolic syndrome in PDB and to determine the relationship between metabolic syndrome and bone-specific alkaline phosphatase levels.Patients and methodsTwenty three patients w...

ea0063p878 | Adrenal and Neuroendocrine Tumours 3 | ECE2019

Metabolic profile of non-functional adrenal adenomas

Batman Adnan , Yener Ozturk Feyza , Masum Canat Muhammed , Erol Rumeysa Selvinaz , Sen Esra Cil , Yıldız Duygu , Altuntas Yuksel

Aim: Metabolic syndrome rates have been studied especially in adrenal gland secreting cortisol and studies on nonfunctional adenomas are limited. In this study, we investigated metabolic parameters and metabolic syndrome frequency in non-functional adrenal adenomas (NFA).Materials and methods: In our study, 55 patients (15 men (27.3%), 40 women (72.7%) who were diagnosed incidentally, unilateral or bilateral localized, hormone-inactive, and with adenoma-...

ea0049ep109 | Clinical case reports - Pituitary/Adrenal | ECE2017

Prolonged zona glomerulosa insuffiency with hyperkalemia in primary hyperaldosteronism after adrenalectomy

Ozturk Feyza Yener , Sen Esra Cil , Erol Rumeysa Selvinaz , Saygili Emre Sedar , Basmaz Seda Erem , Cakir Sezin Dogan , Batman Adnan , Altuntas Yuksel

Introduction: Hyperkalemia due to zona glomerulosa (ZG) insufficiency is generally transient and mild for patients with aldosterone-producing adenoma (APA) after adrenalectomy. We report here a case with prolonged ZG insuffiency requiring long-term mineralocorticoid replacement (MR) therapy.Case report: A 45-years-old female with hypertension and hypokalemia admitted to outpatient clinic with incidentally detected right adrenal adenoma (3 cm) showing sig...

ea0049ep836 | Clinical case reports - Pituitary/Adrenal | ECE2017

Successful management of macroprolactinoma with aromatase inhibitor in a patient with hypogonadotropic hypogonadism

Ozturk Feyza Yener , Sen Esra Cil , Erol R Selvinaz , Cakir Sezin Dogan , Basmaz Seda Erem , Saygili Emre Sedar , Batman Adnan , Altuntas Yuksel

Introduction: Hypogonadism persisting in man with macroprolactinoma requires exogenous testosterone replacement therapy (TRT). But TRT may cause secondary elevations of prolactin. We report here a case of macroprolactinoma and hypogonadotropic hypogonadism with persistently high prolactin level after initiating TRT.Case report: A 28 year-old male was admitted to outpatient clinic with complaints of headache, low libido and blurred vision on left eye for ...

ea0037ep347 | Diabetes (pathiophysiology & epitemiology) | ECE2015

Vitamin D level in diabetic retinopathy

Erol Rumeysa Selvinaz , Erol Muhammet Kazim , Zuhur Sayid Shafi , Ozturk Feyza Yener , Sen Esra Cil , Mavi Aysegul , Canat Masum , Cakmak Dilek Guven , Altuntas Yuksel

Purpose: To determine the relationship between grade of diabetic retinopathy and serum vitamin D levels in diabetic patients.Materials and methods: A total of 173 diabetic patients consisting of patients without retinopathy (n=67), patients with non proliferative diabetic retinopathy (NPDRP group n=47), patients with proliferative diabetic retinopathy (PDRP group n=59) was included in the study. Age and sex matched 55 healthy s...

ea0056gp191 | Pituitary / Growth Hormone ' IGF Axis | ECE2018

Ectopic Cushing’s syndrome secondary to medullary thyroid carcinoma with apparent signs of hypercortisolism: a case report

Canat M Masum , Cakir Sezin Dogan , Yildiz Duygu , Ozturk Feyza Yener , Erol Rumeysa Selvinaz , Sen Esra Cil , Saygili Emre Sedar , Basmaz Seda Erem , Batman Adnan , Altuntas Yuksel

Introduction: Ectopic ACTH syndrome (EAS) is a rare cause of Cushing’s syndrome. EAS is most frequently caused by bronchial carcinoid tumor or small cell lung cancer. Medullary thyroid carcinoma (MTC) is a rare source of EAS, as reported in this case.Case report: A 65-years-old-female with back pain and weight gain referred to our outpatient clinic with determined signs and symptoms of hypercortisolism. She had arterial hypertension, her sister had ...

ea0056p709 | Clinical case reports - Pituitary/Adrenal | ECE2018

Successful management of Cushing’s disease in pregnancy: a case report

Batman Adnan , Ozturk Feyza Yener , Sen Esra Cil , Erol Rumeysa Selvinaz , Canat Muhammed Masum , Saygili Emre Sedar , Cakir Sezin Dogan , Basmaz Seda Eren , Yildiz Duygu , Altuntas Yuksel

Introduction: Cushing’s disease (CD) frequently leads to hypogonadotropic hypogonadism by hypercortisolism and hyperandrogenemia. In the literature, there are totally 96 cases of CD and pregnancy. Only four of 11 cases, operated transsphenoidally, were cured. We aimed to present a case of CD developing pregnancy in which hypercortisolism was successfully controlled by transsphenoidal surgery (TSS) in 2nd trimester.Case report: 28 years old female wa...

ea0056ep84 | Diabetes, Obesity and Metabolism | ECE2018

A case report of MODY 2 treated as type 2 diabetes mellitus in pregnancy

Batman Adnan , Saygili Emre Sedar , Basmaz Seda Eren , Cakir Sezin Dogan , Yildiz Duygu , Ozturk Feyza Yener , Sen Esra Cil , Erol Rumeysa Selvinaz , Canat Muhammed Masum , Altuntas Yuksel

Introduction: Maturity-onset diabetes of young (MODY) type 2 is caused by mutation of the glucokinase gene. It is characterized by mild fasting hyperglicemia and absence of vascular complications. It is estimated that the incidence of gestational diabetes is 3%. We aimed to present a pregestational diabetic case with MODY-type 2 in pregnancy.Case report: A 38-year-old pregnant woman was referred to our clinic for glycemic regulation at 22th week of gesta...

ea0056ep95 | Interdisciplinary endocrinology | ECE2018

A case with autoimmune polyglanduler syndrome type 3A

Batman Adnan , Erol Rumeysa Selvinaz , Ozturk Feyza Yener , Sen Esra Cil , Canat Muhammed Masum , Saygili Emre Sedar , Cakir Sezin Dogan , Basmaz Seda Eren , Yildiz Duygu , Altuntas Yuksel

Introduction: Autoimmune polyendocrine syndromes (APS) are rare endocrinopathies characterized by the coexistence of at least two glandular autoimmune diseases. APS comprise a wide spectrum of autoimmune disorders and are divided into a very rare juvenile (APS type 1) and a more common adult type with (APS 2) or without adrenal failure (APS 3). We present a patient with polyglanduler syndrome type 3a.Case report: A 39-years-old female patient was present...

ea0073aep464 | Pituitary and Neuroendocrinology | ECE2021

The duration of postoperative steroid replacement therapy may not have a predictive role for recurrence risk of Cushing’s disease

Gülnar Zeynalova , Ozturk Feyza Yener , Aslı Büyükkuşcu , Erol Selvinaz , sen Esra Cil , M.Masum Canat , Altuntas Yuksel

ObjectiveIn patients with Cushing’s disease (CD), normal pituitary corticotrophs are suppressed by excessive and persistent cortisol secretion in responce to autonomous ACTH secretion by tumour. Therefore, patients exhibit signs and symptoms of ACTH deficiency shortly after resection of tumour and need steroid replacement therapy (SRT) until hypotalamo-pituitary-adrenal (HPA) axis recovery. We aimed to evaluate whether duration of SRT can serve as a...